157 related articles for article (PubMed ID: 11696152)
1. Life threatening cardiopulmonary failure in an infant following protamine reversal of heparin after cardiopulmonary bypass.
Boigner H; Lechner E; Brock H; Golej J; Trittenwein G
Paediatr Anaesth; 2001 Nov; 11(6):729-32. PubMed ID: 11696152
[TBL] [Abstract][Full Text] [Related]
2. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
Pretorius M; Scholl FG; McFarlane JA; Murphey LJ; Brown NJ
Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
[TBL] [Abstract][Full Text] [Related]
3. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
[TBL] [Abstract][Full Text] [Related]
4. Case 3--2000. Improper administration of protamine during cardiopulmonary bypass.
Karaaslan D; Akpek EA; Sekerci S; Arslan G; Stammers A
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):327-9. PubMed ID: 10890491
[No Abstract] [Full Text] [Related]
5. [A case of twice catastrophic pulmonary vasoconstriction-type shock induced with protamine sulfate].
Inoue S; Miyashita T; Kuro M
Masui; 1997 Jul; 46(7):987-90. PubMed ID: 9251520
[TBL] [Abstract][Full Text] [Related]
6. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass.
Gruenwald CE; Manlhiot C; Chan AK; Crawford-Lean L; Foreman C; Holtby HM; Van Arsdell GS; Richards R; Moriarty H; McCrindle BW
J Am Coll Cardiol; 2010 Nov; 56(22):1794-802. PubMed ID: 21087706
[TBL] [Abstract][Full Text] [Related]
7. Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction.
Comunale ME; Maslow A; Robertson LK; Haering JM; Mashikian JS; Lowenstein E
J Cardiothorac Vasc Anesth; 2003 Jun; 17(3):309-13. PubMed ID: 12827577
[TBL] [Abstract][Full Text] [Related]
8. Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass.
Olsson A; Alfredsson J; Håkansson E; Svedjeholm R; Berglund J; Berg S
Scand Cardiovasc J; 2016; 50(1):58-63. PubMed ID: 26402229
[TBL] [Abstract][Full Text] [Related]
9. The heparin-protamine interaction. A review.
Carr JA; Silverman N
J Cardiovasc Surg (Torino); 1999 Oct; 40(5):659-66. PubMed ID: 10596998
[TBL] [Abstract][Full Text] [Related]
10. Probable reversal of protamine reactions by heparin administration.
Lock R; Hessel EA
J Cardiothorac Anesth; 1990 Oct; 4(5):604-8. PubMed ID: 2132139
[No Abstract] [Full Text] [Related]
11. Heparin reversal with protamine sulfate is not required in atrial fibrillation ablation with suture hemostasis.
Yasar SJ; Bickel T; Zhang S; Akkaya M; Aznaurov SG; Krishnan K; Cuculich PS; Gautam S
J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2811-2817. PubMed ID: 31661173
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass.
Kimmel SE; Sekeres MA; Berlin JA; Ellison N; DiSesa VJ; Strom BL
J Am Coll Cardiol; 1998 Dec; 32(7):1916-22. PubMed ID: 9857872
[TBL] [Abstract][Full Text] [Related]
13. Monitoring and management of anticoagulation in children requiring extracorporeal circulation.
Malviya S
Semin Thromb Hemost; 1997; 23(6):563-7. PubMed ID: 9469631
[TBL] [Abstract][Full Text] [Related]
14. Dramatic post-cardiotomy outcome, due to severe anaphylactic reaction to protamine.
Panos A; Orrit X; Chevalley C; Kalangos A
Eur J Cardiothorac Surg; 2003 Aug; 24(2):325-7. PubMed ID: 12895638
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of heparinase I versus protamine in patients undergoing coronary artery bypass grafting with and without cardiopulmonary bypass.
Stafford-Smith M; Lefrak EA; Qazi AG; Welsby IJ; Barber L; Hoeft A; Dorenbaum A; Mathias J; Rochon JJ; Newman MF;
Anesthesiology; 2005 Aug; 103(2):229-40. PubMed ID: 16052104
[TBL] [Abstract][Full Text] [Related]
16. Heparin removal after cardiopulmonary bypass in a patient with adverse reaction to protamine.
Tevaearai HT; Jegger D; Mueller XM; Horisberger J; von Segesser LK
Thorac Cardiovasc Surg; 1998 Oct; 46(5):303-4. PubMed ID: 9885123
[TBL] [Abstract][Full Text] [Related]
17. Effect of prostaglandin E1 on pulmonary hypertension after protamine injection during cardiac surgery.
Abe K; Sakakibara T; Miyamoto Y; Ohnishi K
Eur J Clin Pharmacol; 1998 Mar; 54(1):21-5. PubMed ID: 9591925
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of low molecular weight heparin by polybrene prevents thromboxane release and severe pulmonary hypertension in awake sheep.
Montalescot G; Zapol WM; Carvalho A; Robinson DR; Torres A; Lowenstein E
Circulation; 1990 Nov; 82(5):1754-64. PubMed ID: 2171807
[TBL] [Abstract][Full Text] [Related]
19. Adverse events after protamine administration following cardiopulmonary bypass in infants and children.
Seifert HA; Jobes DR; Ten Have T; Kimmel SE; Montenegro LM; Steven JM; Nicolson SC; Strom BL
Anesth Analg; 2003 Aug; 97(2):383-389. PubMed ID: 12873922
[TBL] [Abstract][Full Text] [Related]
20. [About severe shock after protamine infusion in a neonate undergoing cardiopulmonary bypass].
Ponvert C
Ann Fr Anesth Reanim; 2014 Jan; 33(1):48-9. PubMed ID: 24378040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
